Literature DB >> 34539913

Malignancy Rates of Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cases: A Tertiary Center Study.

S Erdogan-Durmus1, H Balta2, R Demirtas3, A Kurt3.   

Abstract

AIM: To evaluate the malignancy rates of Atypia of undetermined significance /follicular lesion of undetermined significance (AUS/FLUS) cases in the light of clinical and sonographic features.
MATERIAL AND METHODS: The percentage of AUS/FLUS cases, second fine needle aspiration cytology (FNAC) results, cyto-histopathological correlations and risk of malignancy were analyzed.
RESULTS: 113 out of 1461 thyroid FNAC samples (7.7%) were diagnosed as AUS/FLUS and included in the study. Seventy three out of 113 cases (64.6 %) underwent repeat biopsies or surgery. From 45 cases repeat biopsies were taken and 28 had thyroidectomy or lobectomy. There was a significant relation between nodule size and underwent surgery or repeat FNAC (p=0.036). Malignancy rate was 24.6% for cases which had any managements. The malignancy rates were higher in AUS/FLUS cases with cytological atypia (28.8%). After surgery the most common malignancy was papillary thyroid carcinoma, followed by follicular carcinoma.
CONCLUSION: The risk of malignancy of AUS/FLUS cases is quite high because of the heterogeneity of the group. The sub-classification of this category according to cytological or/and architecture atypia may be more useful in predicting malignancy risk. Further larger studies with ancillary techniques including molecular analysis may be more useful in determining the malignancy risk and appropriate management of this heterogeneous category. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  AUS/FLUS; Bethesda system; malignancy; thyroid nodules

Year:  2021        PMID: 34539913      PMCID: PMC8417486          DOI: 10.4183/aeb.2021.77

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  29 in total

1.  Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?

Authors:  Paul A VanderLaan; Ellen Marqusee; Jeffrey F Krane
Journal:  Am J Clin Pathol       Date:  2011-05       Impact factor: 2.493

2.  Malignancy rate in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance - An institutional experience.

Authors:  Smita Chandra; Harish Chandra; Sampan S Bisht
Journal:  J Cytol       Date:  2017 Jul-Sep       Impact factor: 1.000

Review 3.  Next generation immunohistochemistry: Emerging substitutes to genetic testing?

Authors:  Juliana Andrici; Anthony J Gill; Jason L Hornick
Journal:  Semin Diagn Pathol       Date:  2017-06-27       Impact factor: 3.464

4.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Authors:  Yuri E Nikiforov; Raja R Seethala; Giovanni Tallini; Zubair W Baloch; Fulvio Basolo; Lester D R Thompson; Justine A Barletta; Bruce M Wenig; Abir Al Ghuzlan; Kennichi Kakudo; Thomas J Giordano; Venancio A Alves; Elham Khanafshar; Sylvia L Asa; Adel K El-Naggar; William E Gooding; Steven P Hodak; Ricardo V Lloyd; Guy Maytal; Ozgur Mete; Marina N Nikiforova; Vania Nosé; Mauro Papotti; David N Poller; Peter M Sadow; Arthur S Tischler; R Michael Tuttle; Kathryn B Wall; Virginia A LiVolsi; Gregory W Randolph; Ronald A Ghossein
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

Review 5.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

6.  The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology.

Authors:  James T Broome; Carmen C Solorzano
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

7.  Atypical follicular cells with equivocal features of papillary thyroid carcinoma is not a low-risk cytologic diagnosis.

Authors:  Martin H Luu; Andrew H Fischer; Thomas J Stockl; Latha Pisharodi; Christopher L Owens
Journal:  Acta Cytol       Date:  2011-12-09       Impact factor: 2.319

8.  Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.

Authors:  Yuri E Nikiforov; Sally E Carty; Simon I Chiosea; Christopher Coyne; Umamaheswar Duvvuri; Robert L Ferris; William E Gooding; Shane O LeBeau; N Paul Ohori; Raja R Seethala; Mitchell E Tublin; Linwah Yip; Marina N Nikiforova
Journal:  Thyroid       Date:  2015-09-10       Impact factor: 6.568

9.  Evaluation of thyroid nodules classified as Bethesda category III on FNAC.

Authors:  Shiwani Garg; Leena P Naik; Kanchan S Kothari; Gwendolyn C Fernandes; Mona A Agnihotri; Jagruti C Gokhale
Journal:  J Cytol       Date:  2017 Jan-Mar       Impact factor: 1.000

10.  The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study.

Authors:  Bakiarathana Anand; Anita Ramdas; Marie Moses Ambroise; Nirmal P Kumar
Journal:  J Thyroid Res       Date:  2020-04-16
View more
  2 in total

1.  VITAMIN D LEVEL AND ITS RELATIONSHIP WITH CANCER STAGE IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA.

Authors:  A M Cocolos; S Vladoiu; A Caragheorgheopol; A M Ghemigian; D Ioachim; C Poiana
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Apr-Jun       Impact factor: 1.104

2.  Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III.

Authors:  Xiaoli Liu; Jingjing Wang; Wei Du; Liyuan Dai; Qigen Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-16       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.